Mammograms miss up to 50% of cancers in women with dense breasts.(Left) BI-RADS classification of breast density using a 4-level (A-D) scale. Iowa Radiology3.(Right) Imaging of cancer in fatty vs dense breast tissue4.
Our generative AI model utilizes tumor-derived oncRNAs discovered in TCGA breast cancer samples for downstream applications in serum. The model is trained to predict presence or absence of invasive breast cancer while minimizing the impact of technical variations such as supplier and batch effects.
JK, AK, KM, AH, DN, SC, RH, NT, JW, XZ, NC, HL, AH, FH, PA, LS, BA are consultants or full-time employees of Exai Bio. PA and BA are co-founders, stockholders, and full-time employees of Exai Bio. HG is a co-founder, stockholder, and advisor of Exai Bio.